Aboubakar joined IDDO in February 2022 as an EDCTP-Clinical Research and Product Development Fellow from the Centre MURAZ/NIPH in Burkina Faso.

He trained as a pharmacologist and has research interests on epidemiological aspect of malaria and other infectious diseases such as Covid-19. Over the past five years, his research has focused on in vitro and in vivo assessment of antimalarial drugs and in vitro evaluation of anti-SARS-CoV-2 activity.

At IDDO, he is looking forward to learn and develop broader skills on biostatistics, clinical research data management, and design and conduct of systematic reviews.